Validating antibodies for research applications

December 9, 2021, 13:30 – 14:30


Online event via Zoom

Validating antibodies for research applications

Virtual Event Virtual Event

December 9 @ 13:30 14:30 CET

Will Howat, Senior director of Antibody Validation and Characterization at Abcam


Validation of antibodies for use in scientific research is a tricky and time-consuming process which can stifle scientific progress. During this seminar, I will demonstrate why we need validation and the tools that are available to help.


Will Howat leads Abcam’s approach to product validation and technical quality globally as Senior Director of Antibody Validation & Characterization. Prior to joining Abcam in 2018, he worked at AstraZeneca as Team Leader of its Molecular Pathology Group, where his team developed biomarker assays for preclinical, Phase 1 and Phase 2 clinical trials. Before that he was at the Cancer Research UK’s Cambridge Institute, where he set up and ran the Histopathology/ISH core facility for 9 years. He has also worked at the Wellcome Sanger Institute on the Atlas of Protein Expression and was responsible for R & D within the Immunohistochemistry group.

Will has a BSc (Hons) in Immunology & Pharmacology from the University of Strathclyde and a PhD in Pathology from the University of Southampton. His publications span key journals such as The Lancet, Nature, Science, Nature Genetics, American Journal of Pathology, and the Journal of Pathology.


Fabio Socciarelli MD, Henrik J. Johansson PhD

Last updated: 2021-12-07

Content Responsible: David Gotthold(